mianserin has been researched along with Idiopathic Parkinson Disease in 9 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tagai, K | 2 |
| Nagata, T | 2 |
| Shinagawa, S | 2 |
| Tsuno, N | 1 |
| Ozone, M | 1 |
| Nakayama, K | 2 |
| Hagikura, M | 1 |
| Iwamoto, K | 1 |
| Aleksic, B | 1 |
| Ozaki, N | 1 |
| Pae, CU | 1 |
| Gordon, PH | 1 |
| Pullman, SL | 1 |
| Louis, ED | 1 |
| Frucht, SJ | 1 |
| Fahn, S | 1 |
| Ikeguchi, K | 2 |
| Kuroda, A | 2 |
| Friedman, JH | 1 |
| Normann, C | 1 |
| Hesslinger, B | 1 |
| Frauenknecht, S | 1 |
| Berger, M | 1 |
| Walden, J | 1 |
| Pact, V | 1 |
| Giduz, T | 1 |
9 other studies available for mianserin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
Topics: Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Female; Halluc | 2013 |
What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Mianserin; Middle Aged | 2012 |
A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease.
Topics: Antidepressive Agents, Tricyclic; Basal Ganglia Diseases; Depressive Disorder; Female; Hallucination | 2013 |
Comments on 'what is a rational antidepressant treatment for major depression in patients with Parkinson's disease?'.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Mianserin; Parkinson D | 2013 |
Mirtazapine in Parkinsonian tremor.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mir | 2002 |
Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antiparkinson Agents; Dose-Response Relationship, Dru | 1995 |
Comments and reply on Ikeguchi and Kuroda: Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.
Topics: Antidepressive Agents, Second-Generation; Antiparkinson Agents; Humans; Mianserin; Parkinson Disease | 1996 |
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Depressive Disorder; Drug Interaction | 1997 |
Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias.
Topics: Adrenergic alpha-Antagonists; Aged; Dyskinesia, Drug-Induced; Dyskinesias; Female; Humans; Levodopa; | 1999 |